EX-10.1



 Exhibit 10.1 

FIREEYE, INC. 
 $400,000,000
1.000% CONVERTIBLE SENIOR NOTES DUE 2035 
 $400,000,000 1.625% CONVERTIBLE SENIOR NOTES DUE 2035 

PURCHASE AGREEMENT 
 May 27, 2015 







 May 27, 2015 

Morgan Stanley & Co. LLC 
 J.P. Morgan Securities LLC

 As Representatives of the several 
   Initial
Purchasers named 
   in Schedule I hereto 

c/o Morgan Stanley & Co. LLC 

      1585 Broadway 

      New York, New York 10036 

c/o J.P. Morgan Securities LLC 

      383 Madison Avenue 

      New York, New York 10179 

Ladies and Gentlemen: 
 FireEye, Inc., a
Delaware corporation (the “Company”), proposes to issue and sell to the several purchasers named in Schedule I hereto (the “Initial Purchasers”), for whom you are acting as representatives (the
“Representatives”), $400,000,000 principal amount of its 1.000% Convertible Senior Notes Due 2035 (the “Series A Notes”) and $400,000,000 principal amount of its 1.625% Convertible Senior Notes due 2035 (the
“Series B Notes,” and together with the Series A Notes, the “Firm Securities”). The Series A Notes will be issued pursuant to the provisions of an indenture to be dated as of the Closing Date (as defined below) (the
“Series A Indenture”) between the Company and U.S. Bank National Association, as Trustee (the “Trustee”), and the Series B Notes will be issued pursuant to the provisions of an indenture to be dated as of the
Closing Date (the “Series B Indenture,” and together with the Series A Indenture, the “Indentures”) between the Company and the Trustee. The Company also proposes to issue and sell to the Initial Purchasers not more
than an additional $60,000,000 principal amount of its Series A Notes and an additional $60,000,000 principal amount of its Series B Notes (together, the “Additional Securities”) if and to the extent that you, as Representatives of
the offering, shall have determined to exercise, on behalf of the Initial Purchasers, the right to purchase such Additional Securities granted to the Initial Purchasers in Section 2 hereof. The Firm Securities and the Additional
Securities are hereinafter collectively referred to as the “Securities.” The Securities will be convertible into cash, shares of the Company’s Common Stock, par value $0.0001 per share (the “Underlying
Securities”), or a combination of cash and Underlying Securities, at the Company’s option. 
 The Securities and the
Underlying Securities will be offered without being registered under the Securities Act of 1933, as amended (the “Securities Act”), to qualified institutional buyers in compliance with the exemption from registration provided by
Rule 144A under the Securities Act. 







 In connection with the sale of the Securities, the Company has prepared a preliminary offering
memorandum (the “Preliminary Memorandum”) and will prepare a final offering memorandum (the “Final Memorandum”) including or incorporating by reference a description of the terms of the Securities and the Underlying
Securities, the terms of the offering and a description of the Company. For purposes of this Agreement, “Additional Written Offering Communication” means any written communication (as defined in Rule 405 under the Securities Act)
that constitutes an offer to sell or a solicitation of an offer to buy the Securities other than the Preliminary Memorandum or the Final Memorandum; “Time of Sale Memorandum” means the Preliminary Memorandum together with each
Additional Written Offering Communication or other information, if any, each identified in Schedule II hereto under the caption Time of Sale Memorandum; and “General Solicitation” means any offer to sell or solicitation
of an offer to buy the Securities by any form of general solicitation or advertising (as those terms are used in Regulation D under the Securities Act). As used herein, the terms Preliminary Memorandum, Time of Sale Memorandum and Final Memorandum
shall include the documents, if any, incorporated by reference therein on the date hereof. The terms “supplement,” “amendment” and “amend” as used herein with respect to the Preliminary Memorandum,
the Time of Sale Memorandum, the Final Memorandum or any Additional Written Offering Communication shall include all documents subsequently filed by the Company with the Securities and Exchange Commission (the “Commission”) pursuant
to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are deemed to be incorporated by reference therein. In connection with the offering of the Securities, the Company is entering into prepaid forward stock
purchase transactions with Morgan Stanley & Co. LLC (the “Prepaid Forward Agreements”). 
 1. Representations
and Warranties. The Company represents and warrants to, and agrees with each of the Representatives that: 
 (a) (i) Each
document, if any, filed or to be filed pursuant to the Exchange Act and incorporated by reference in the Preliminary Memorandum, the Time of Sale Memorandum or the Final Memorandum complied or will comply when so filed in all material respects with
the Exchange Act and the applicable rules and regulations of the Commission thereunder, (ii) the Time of Sale Memorandum does not, and at the time of each sale of the Securities in connection with the offering when the Final Memorandum is not
yet available to prospective purchasers and at the Closing Date (as defined in Section 4), the Time of Sale Memorandum, as then amended or supplemented by the Company, if applicable, will not, contain any untrue statement of a material fact or omit
to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, (iii) any Additional Written Offering Communication prepared, used or referred to by the Company,
when considered together with the Time of Sale Memorandum, at the time of its use did not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, (iv) any General Solicitation that is not an Additional Written Offering Communication, made by the Company or by the Initial Purchaser with the consent of the Company, when considered together with
the Time of Sale Memorandum, at the time when made or used did not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading and (v) the Preliminary Memorandum does not contain and the Final Memorandum, in the form used by the Initial Purchasers to confirm sales and on the Closing Date (as defined in Section 4), will not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not 

  
 2 








 
misleading, except that the representations and warranties set forth in this paragraph do not apply to statements or omissions in the Preliminary Memorandum, the Time of Sale Memorandum, the
Final Memorandum, Additional Written Offering Communication or General Solicitation based upon information relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representatives expressly for use
therein. 
 (b) Except for the Additional Written Offering Communications, if any, identified in Schedule II
hereto, including electronic road shows, if any, furnished to the Representatives before first use, the Company has not prepared, used or referred to, and will not, without the Representatives’ prior consent, prepare, use or refer to, any
Additional Written Offering Communication. 
 (c) The Company has been duly incorporated, is validly existing as a
corporation in good standing under the laws of the State of Delaware, has the corporate power and authority to own or lease its property and to conduct its business as described in the Time of Sale Memorandum and is duly qualified to transact
business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good standing would not
have a material adverse effect on the Company and its subsidiaries, taken as a whole. 
 (d) Each subsidiary of the Company
has been duly organized, is validly existing and in good standing under the laws of the jurisdiction of its organization (to the extent such concepts are applicable under such laws), has the corporate power and authority to own or lease its property
and to conduct its business as described in the Time of Sale Memorandum and is duly qualified to transact business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires
such qualification, except to the extent that the failure to be so qualified or be in good standing would not have a material adverse effect on the Company and its subsidiaries, taken as a whole; all of the issued shares of capital stock of each
subsidiary of the Company have been duly and validly authorized and issued, are fully paid and non-assessable and are owned directly by the Company, free and clear of all liens, encumbrances, equities or claims, except to the extent that such liens,
encumbrances, equities or claims would not be reasonably likely to have a material adverse effect on the Company and its subsidiaries, taken as a whole. 

(e) This Agreement has been duly authorized, executed and delivered by the Company. 

(f) The authorized capital stock of the Company conforms as to legal matters to the description thereof contained in each of
the Time of Sale Memorandum and the Final Memorandum. 
 (g) The shares of Common Stock of the Company outstanding prior to
the issuance of the Securities have been duly authorized and are validly issued, fully paid and non-assessable. 
 (h) The
Securities have been duly authorized and, when executed and authenticated in accordance with the provisions of the Indentures and delivered to and paid for by the Initial Purchasers in accordance with the terms of this Agreement, will be


  
 3 








 
valid and binding obligations of the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally
and equitable principles of general applicability, and will be entitled to the benefits of the Indentures pursuant to which such Securities are to be issued, and the Securities and the Indentures will conform in all material respects to the
descriptions thereof in each of the Time of Sale Memorandum and the Final Memorandum. 
 (i) The maximum number of Underlying
Securities initially issuable upon conversion of the Securities (assuming the Company elects to physically settle the Securities upon conversion and the maximum conversion rate under any make-whole adjustment applies (such maximum number, the
“Conversion Shares”)) have been duly authorized and reserved for issuance and, when issued upon conversion of the Securities in accordance with the terms of the Securities, will be validly issued, fully paid and non-assessable, and the issuance of the Underlying Securities will not be subject to any preemptive or similar rights. 

(j) The Prepaid Forward Agreements have been duly authorized, executed and delivered by, and are valid and binding agreements
of, the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally and equitable principles of general applicability; and conform as to legal matters
to the description thereof contained in each of the Time of Sale Memorandum and the Final Memorandum. 
 (k) Each Indenture
has been duly authorized, and the Company has full right, power and authority to execute and deliver each Indenture, and to perform its obligations thereunder; on the Closing Date, each Indenture will have been duly executed and delivered by the
Company and, when duly executed and delivered by the Trustee, will be a valid and binding agreement of, the Company, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’
rights generally and equitable principles of general applicability. 
 (l) The execution and delivery by the Company of, and
the performance by the Company of its obligations under, this Agreement, the Indentures, the Prepaid Forward Agreements and the Securities will not contravene any provision of (i) applicable law, (ii) the certificate of incorporation or
bylaws of the Company, (iii) any agreement or other instrument binding upon the Company or any of its subsidiaries, or (iv) any judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company or any
subsidiary, except that in the cases of (i) and (iii) as would not, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole, or on the ability of the Company to perform its
obligations under this Agreement, the Indentures, the Prepaid Forward Agreements or the Securities, and no consent, approval, authorization or order of, or qualification with, any governmental body or agency is required for the performance by the
Company of its obligations under this Agreement, the Indentures, the Prepaid Forward Agreements or the Securities, except such as may be required by the securities or Blue Sky laws of the various states or foreign jurisdictions in connection with
the offer and sale of the Securities. 
 (m) There has not occurred any material adverse change, or any development involving
a prospective material adverse change, in the condition, financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Time of Sale Memorandum provided to
prospective purchasers of the Securities. 

  
 4 








 (n) The Company is not (i) in violation of its certificate of incorporation
or bylaws; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage,
deed of trust, loan agreement or other agreement or instrument to which the Company is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company is subject; or (iii), to its
knowledge, in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (ii) and (iii) above, for any such default or
violation that would not, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole. 

(o) Other than proceedings accurately described in all material respects in the Time of Sale Memorandum, there are no legal or
governmental proceedings pending or, to the Company’s knowledge, threatened to which the Company or any of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject other than proceedings
that would not have a material adverse effect on the Company and its subsidiaries, taken as a whole, or on the power or ability of the Company to perform its obligations under this Agreement, the Indentures, the Prepaid Forward Agreements or the
Securities or to consummate the transactions contemplated by the Time of Sale Memorandum. 
 (p) The Company and its
subsidiaries (i) are in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants
or contaminants (“Environmental Laws”), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance
with all terms and conditions of any such permit, license or approval, except where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of
such permits, licenses or approvals would not, singly or in the aggregate, be reasonably likely to have a material adverse effect on the Company and its subsidiaries, taken as a whole. 

(q) There are no costs or liabilities associated with Environmental Laws (including, without limitation, any capital or
operating expenditures required for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties) which
would, singly or in the aggregate, be reasonably likely to have a material adverse effect on the Company and its subsidiaries, taken as a whole. 

(r) The Company is not, and after giving effect to the transactions contemplated by the Prepaid Forward Agreements and the
offering and sale of the Securities and the application of the proceeds thereof as described in the Final Memorandum will not be, required to register as an “investment company” as such term is defined in the Investment Company Act of
1940, as amended (the “Investment Company Act”). 

  
 5 








 (s) Neither the Company nor any affiliate (as defined in Rule 501(b) of
Regulation D under the Securities Act, an “Affiliate”) of the Company has directly, or through any agent (other than any agent that is an Initial Purchaser, as to which no representation is given), (i) sold, offered for sale,
solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the Securities Act) which is or will be integrated with the sale of the Securities in a manner that would require the registration under the Securities Act of
the Securities, (ii) made any General Solicitation that is not an Additional Written Offering Communication other than General Solicitations listed on Schedule II hereto or those made with the prior written consent of Morgan
Stanley & Co. LLC and J.P. Morgan Securities LLC, or (iii) offered, solicited offers to buy or sold the Securities in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act. 

(t) It is not necessary in connection with the offer, sale and delivery of the Securities to the Initial Purchasers in the
manner contemplated by this Agreement to register the Securities under the Securities Act or to qualify the Indentures under the Trust Indenture Act of 1939, as amended. 

(u) The Securities satisfy the requirements set forth in Rule 144A(d)(3) under the Securities Act. 

(v) Neither (i) the Company nor any of its subsidiaries or controlled affiliates, (ii) any director or officer of the
Company or any of its subsidiaries or controlled affiliates, nor (iii) to the Company’s knowledge, any employee, agent or representative of the Company or of any of its subsidiaries or affiliates acting on behalf of the Company or any of
its subsidiaries or controlled affiliates, has taken or will take any action in furtherance of an offer, payment, promise to pay, or authorization or approval of the payment or giving of money, property, gifts or anything else of value, directly or
indirectly, to any “government official” (including any officer or employee of a government or government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf
of any of the foregoing, or any political party or party official or candidate for political office) to improperly influence official action or secure an improper advantage for the Company or its subsidiaries; and the Company and its subsidiaries
and controlled affiliates have conducted their businesses in compliance with applicable anti-corruption laws and have instituted and maintained and will continue to maintain policies and procedures designed to promote and achieve compliance with
such laws. 
 (w) The operations of the Company and its subsidiaries are and have been conducted at all times in material
compliance with all applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and
Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of jurisdictions where the Company and its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules,
regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or
body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. 

  
 6 








 (x) (i) Neither the Company nor any of its subsidiaries, nor any director or
officer thereof, nor, to the Company’s knowledge, any employee, agent, controlled affiliate or representative of the Company or any of its subsidiaries, is an individual or entity (“Person”) that is, or is owned or controlled
by a Person that is: 
 (A) the subject of any sanctions administered or enforced by the U.S. Department of Treasury’s
Office of Foreign Assets Control (“OFAC”), the United Nations Security Council (“UNSC”), the European Union (“EU”), Her Majesty’s Treasury (“HMT”), or other relevant sanctions
authority (collectively, “Sanctions”), nor 
 (B) located, organized or resident in a country or territory
that is the subject of Sanctions (including, without limitation, Cuba, Iran, North Korea, Sudan and Syria). 
 (ii) The
Company will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person: 

(A) to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of
such funding or facilitation, is the subject of Sanctions; or 
 (B) in any other manner that will result in a violation of
Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise). 

(iii) For the past 5 years, the Company and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in,
and will not engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions. 

(y) The Company and its subsidiaries have filed all federal, state, local and foreign tax returns required to be filed through
the date of this Agreement or have requested extensions thereof (except where the failure to file would not, individually or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole) and have paid all
taxes required to be paid thereon (except for cases in which the failure to file or pay would not have a material adverse effect on the Company and its subsidiaries, taken as a whole, or, except as currently being contested in good faith and for
which reserves required by U.S. generally accepted accounting principles (“U.S. GAAP”) have been created in the financial statements of the Company), and no tax deficiency has been determined adversely to the Company or any of its
subsidiaries which has had (nor does the Company nor any of its subsidiaries have any notice or knowledge of any tax deficiency which could reasonably be expected to be determined adversely to the Company or its subsidiaries and which could
reasonably be expected to have) a material adverse effect on the Company and its subsidiaries, taken as a whole. 
 (z) The
Company and each of its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations;
(ii) transactions are recorded as necessary to permit preparation of financial statements in 

  
 7 








 
conformity with U.S. GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; (iv) the
recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v) the interactive data in eXtensible Business Reporting Language included or
incorporated by reference in the Preliminary Memorandum, the Time of Sale Memorandum or the Final Memorandum is accurate. Except as described in the Time of Sale Memorandum, since the end of the Company’s most recent audited fiscal year, there
has been (i) no material weakness in the Company’s internal control over financial reporting (whether or not remediated) and (ii) no change in the Company’s internal control over financial reporting that has materially affected,
or is reasonably likely to materially affect, the Company’s internal control over financial reporting. 
 (aa) The
interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Preliminary Memorandum, the Time of Sale Memorandum or the Final Memorandum fairly presents the information called for in all material respects
and has been prepared in accordance with the Commission’s rules and guidelines applicable thereto. 
 (bb) The financial
statements of the Company in each of the Time of Sale Memorandum and the Final Memorandum present fairly the financial position of the Company as of the dates indicated and the results of its operations and cash flows for the periods specified. Such
financial statements have been prepared in conformity with U.S. GAAP applied on a consistent basis throughout the periods involved. 

(cc) To the extent required under applicable rules, the Company maintains disclosure controls and procedures that comply with
the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that material information relating to the Company and its subsidiaries is made known to the Company’s principal executive officer and
principal financial officer by others within those entities; and such disclosure controls and procedures are effective. 

(dd) Subsequent to the respective dates as of which information is given in each of the Time of Sale Memorandum and the Final
Memorandum, and except as disclosed in the Time of Sale Memorandum and the Final Memorandum, (i) the Company and its subsidiaries have not incurred any material liability or obligation, direct or contingent, nor entered into any material
transaction; (ii) the Company has not purchased any of its outstanding capital stock other than from its employees or other service providers in connection with the termination of their service, nor declared, paid or otherwise made any dividend
or distribution of any kind on its capital stock other than ordinary and customary dividends; and (iii) there has not been any material change in the capital stock, short-term debt or long-term debt of the Company and its subsidiaries, except
in each case as described in each of the Time of Sale Memorandum and the Final Memorandum, respectively. 
 (ee) The Company
and its subsidiaries do not own any real property. The Company and its subsidiaries have good and marketable title to all personal property owned by them which is material to the business of the Company and its subsidiaries taken as a whole, in each
case free and clear of all liens, encumbrances and defects except such as are described in the Time of Sale Memorandum or such as do not materially diminish the value of such property and do not materially interfere with the use made and


  
 8 








 
proposed to be made of such property by the Company and its subsidiaries; and any real property and buildings held under lease by the Company and its subsidiaries are held by them under valid,
subsisting and, to the Company’s knowledge, enforceable leases with such exceptions as are not material and do not materially interfere with the use made and proposed to be made of such property and buildings by the Company and its
subsidiaries, in each case except as described in the Time of Sale Memorandum. 
 (ff) The Company and its subsidiaries own
or possess, or can acquire on commercially reasonable terms, all material patents, patent rights, licenses, inventions, copyrights, know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information,
systems or procedures), trademarks, service marks and trade names currently employed by them in connection with the business now conducted by them (the “Company Intellectual Property”), and, except as disclosed in the Time of Sale
Memorandum, neither the Company nor any of its subsidiaries has received any notice of infringement of or conflict with rights of others with respect to any of the foregoing or otherwise which, singly or in the aggregate, if the subject of an
unfavorable decision, ruling or finding, would reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. Except as disclosed in the Time of Sale Memorandum, or as would not, individually or in
the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole: (i) to the Company’s knowledge, there are no third parties who have been able to establish any material rights to any Company Intellectual
Property, except for the retained rights of the owners of the Company Intellectual Property that is licensed to the Company; (ii) there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding or claim by others
(A) challenging the validity, enforceability or scope of any Company Intellectual Property or (B) challenging the Company’s rights or any of its subsidiaries’ rights in or to any Company Intellectual Property; and
(iii) there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding or claim by others that the Company or any of its subsidiaries materially infringes or misappropriates any intellectual property or other
proprietary rights of others, and neither the Company nor any of its subsidiaries is aware of any fact which would form a reasonable basis for any such action, suit, proceeding or claim. 

(gg) No material labor dispute with the employees of the Company or any of its subsidiaries exists, except as described in the
Time of Sale Memorandum, or, to the knowledge of the Company, is imminent; and the Company is not aware of any existing, threatened or imminent labor disturbance by the employees of any of its principal suppliers, manufacturers or contractors that
could have a material adverse effect on the Company and its subsidiaries, taken as a whole. 
 (hh) The Company and each of
its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are, in the Company’s reasonable judgment, prudent and customary in the businesses in which they are engaged;
neither the Company nor any of its subsidiaries has been refused any insurance coverage sought or applied for; and neither the Company nor any of its subsidiaries has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not be reasonably likely to have a material adverse effect on the Company and its
subsidiaries, taken as a whole, except as described in the Time of Sale Memorandum. 

  
 9 








 (ii) The Company and its subsidiaries possess all certificates, authorizations
and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct their respective businesses, except where the failure to obtain such certificates, authorizations or permits would not, individually or in
the aggregate, be reasonably likely to have a material adverse effect on the Company and its subsidiaries, taken as a whole, and neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or
modification of any such certificate, authorization or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a material adverse effect on the Company and its subsidiaries, taken as a
whole, except as described in the Time of Sale Memorandum. 
 (jj) The Company has timely made all filings required to be
made by it pursuant to the Exchange Act, and the rules and regulations promulgated thereunder. 
 2. Agreements to Sell and Purchase.
The Company hereby agrees to sell to the several Initial Purchasers, and each Initial Purchaser, upon the basis of the representations and warranties herein contained, but subject to the conditions hereinafter stated, agrees, severally and not
jointly, to purchase from the Company the respective principal amount of Firm Securities set forth in Schedule I hereto opposite its name at a purchase price of 97.50% of the principal amount thereof (the “Purchase
Price”) plus accrued interest, if any, to the Closing Date. 
 On the basis of the representations and warranties contained in this
Agreement, and subject to its terms and conditions, the Company agrees to sell to the Initial Purchasers the Additional Securities, and the Initial Purchasers shall have the right to purchase, severally and not jointly, up to $60,000,000 principal
amount of Series A Notes and up to $60,000,000 principal amount of Series B Notes, in each case representing the Additional Securities at the Purchase Price plus accrued interest, if any, to the date of payment and delivery. The Representatives may
exercise this right on behalf of the Initial Purchasers in whole or from time to time in part by giving written notice to the Company; provided that any Option Closing Date (as defined below) shall occur within a period (the “Exercise
Period”) of thirteen calendar days from, and including, the Closing Date. Any exercise notice shall specify the principal amount of Additional Securities to be purchased by the Initial Purchasers and the date on which such Additional
Securities are to be purchased. Each purchase date must be within the Exercise Period, and must be at least one business day after the written notice is given and may not be earlier than the closing date for the Firm Securities nor later than five
business days after the date of such notice. On each day, if any, that Additional Securities are to be purchased (an “Option Closing Date”), each Initial Purchaser agrees, severally and not jointly, to purchase the principal amount
of Additional Securities (subject to such adjustments to eliminate fractional Securities as the Representatives may determine) that bears the same proportion to the total principal amount of Additional Securities to be purchased on such Option
Closing Date as the principal amount of Firm Securities set forth in Schedule I opposite the name of such Initial Purchaser bears to the total principal amount of Firm Securities. 

3. Terms of Offering. The Representatives have advised the Company that the Initial Purchasers will make an offering of the Securities
purchased by the Initial Purchasers hereunder as soon as practicable after this Agreement is entered into as in their judgment is advisable. 

4. Payment and Delivery. Payment for the Firm Securities shall be made to the Company in Federal or other funds immediately available in
New York City against delivery of such Firm Securities for the respective accounts of the several Initial Purchasers at 10:00 a.m., New York City time, on June 2, 2015, or at such other time on the same or such other date, not later than
June 9, 2015, as shall be designated in writing by the Representatives. The time and date of such payment are hereinafter referred to as the “Closing Date.” 

  
 10 








 Payment for any Additional Securities shall be made to the Company in Federal or other funds
immediately available in New York City against delivery of such Additional Securities for the respective accounts of the several Initial Purchasers at 10:00 a.m., New York City time, on the date specified in the corresponding notice described
in Section 2 or at such other time on the same or on such other date, in any event not later than the last day of the Exercise Period, as shall be designated in writing by the Representatives. 

The Securities shall be in definitive form or global form, as specified by the Representatives, and registered in such names and in such
denominations as the Representatives shall request in writing not later than one full business day prior to the Closing Date or the applicable Option Closing Date, as the case may be. The Securities shall be delivered to the Representatives on the
Closing Date or an Option Closing Date, as the case may be, for the respective accounts of the several Initial Purchasers, with any transfer taxes payable in connection with the transfer of the Securities to the Initial Purchasers duly paid, against
payment of the Purchase Price therefor plus accrued interest, if any, to the date of payment and delivery. 
 5. Conditions to the
Initial Purchasers’ Obligations. 
 (a) The several obligations of the Initial Purchasers to purchase and pay for
the Firm Securities on the Closing Date are subject to the following conditions: 
 (i) Subsequent to the execution and
delivery of this Agreement and prior to the Closing Date: 
 (A) there shall not have occurred any downgrading, nor shall
any notice have been given of any intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any of the securities of the Company or any of its
subsidiaries by any “nationally recognized statistical rating organization,” as such term is defined in Section 3(a)(62) of the Exchange Act; and 

(B) there shall not have occurred or shall exist any change, or any development involving a prospective change, in the
condition, financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Time of Sale Memorandum provided to the prospective purchasers of the Securities that, in
the Representatives’ judgment, is material and adverse and that makes it, in the Representatives’ judgment, impracticable or inadvisable to market the Securities on the terms and in the manner contemplated in the Time of Sale Memorandum.

 (C) The Representatives shall have received on the Closing Date a certificate, dated the Closing Date and signed by an
executive officer of the Company, to the effect set forth in Section 5(a)(i)(A) and to the effect that the representations and warranties of the Company contained in this Agreement are true and 


  
 11 








 
correct as of the Closing Date and that the Company has complied with all of the agreements and satisfied all of the conditions on its part to be performed or satisfied hereunder on or before the
Closing Date. The officer signing and delivering such certificate may rely upon the best of his or her knowledge as to proceedings threatened. 

(D) The Representatives shall have received on the Closing Date an opinion of Wilson Sonsini Goodrich & Rosati,
Professional Corporation, outside counsel for the Company, dated the Closing Date, to the effect set forth in Exhibit A. Such opinion shall be rendered to the Initial Purchasers at the request of the Company and shall so state therein. 

(E) The Representatives shall have received on the Closing Date an opinion of Davis Polk & Wardwell LLP, counsel for
the Initial Purchasers, dated the Closing Date, in form and substance satisfactory to the Representatives. 
 (F) The
Representatives shall have received on the Closing Date an opinion of Cooley LLP, counsel for the Initial Purchasers, dated the Closing Date, in form and substance satisfactory to the Representatives. 

(G) The Representatives shall have received on each of the date hereof and the Closing Date a letter, dated the date hereof or
the Closing Date, as the case may be, in form and substance satisfactory to the Initial Purchasers, from Deloitte & Touche LLP, independent public accountants, containing statements and information of the type ordinarily included in
accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information contained in or incorporated by reference into the Time of Sale Memorandum and the Final Memorandum; provided
that the letter delivered on the Closing Date shall use a “cut-off date” not earlier than the date hereof. 

(H) The Conversion Shares issuable upon conversion of the Securities shall have been approved for listing, subject to notice
of issuance, by The NASDAQ Global Select Market and reasonably satisfactory evidence of such approval shall have been provided to the Representatives. 

(I) The “lock-up” agreements, each substantially in the form of
Exhibit B hereto, between the Representatives and certain shareholders, officers and directors of the Company relating to sales and certain other dispositions of shares of common stock or certain other securities, delivered to the
Representatives on or before the date hereof, shall be in full force and effect on the Closing Date. 

  
 12 








 (b) The several obligations of the Initial Purchasers to purchase Additional
Securities hereunder are subject to the delivery to the Representatives on the applicable Option Closing Date of the following: 

(i) a certificate, dated the Option Closing Date and signed by an executive officer of the Company, confirming that the
certificate delivered on the Closing Date pursuant to Section 5(a)(i)(C) hereof remains true and correct as of such Option Closing Date; 

(ii) an opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation, outside counsel for the Company, dated
the Option Closing Date, relating to the Additional Securities to be purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section 5(a)(i)(D) hereof; 

(iii) an opinion of Davis Polk & Wardwell LLP, counsel for the Initial Purchasers, dated the Option Closing Date,
relating to the Additional Securities to be purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section 5(a)(i)(E) hereof; 

(iv) an opinion of Cooley LLP, counsel for the Initial Purchasers, dated the Option Closing Date, relating to the Additional
Securities to be purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section 5(a)(i)(F) hereof; 

(v) a letter dated the Option Closing Date, in form and substance satisfactory to the Initial Purchasers, from
Deloitte & Touche LLP, independent public accountants, substantially in the same form and substance as the letter furnished to the Initial Purchasers pursuant to Section 5(a)(i)(G) hereof; provided that the letter delivered on
the Option Closing Date shall use a “cut-off date” not earlier than three business days prior to such Option Closing Date; 

(vi) the Conversion Shares issuable upon conversion of the Securities shall have been approved for listing, subject to notice
of issuance, by The NASDAQ Global Select Market and reasonably satisfactory evidence of such approval shall have been provided to the Representatives; and 

(vii) such other documents as the Representatives may reasonably request with respect to the good standing of the Company, the
due authorization, execution and authentication of the Additional Securities to be sold on such Option Closing Date and other matters related to the execution and authentication of such Additional Securities. 

6. Covenants of the Company. The Company covenants with each Initial Purchaser as follows: 

(a) To furnish to the Representatives in New York City, without charge, as soon as reasonably practicable, but in no event
later than 10:00 a.m. New York City time on the business day next succeeding the date of this Agreement and during the period mentioned in Section 6(d) or (e), as many copies of the Time of Sale Memorandum, the Final Memorandum, any
documents incorporated by reference therein and any supplements and amendments thereto as the Representatives may reasonably request. 

  
 13 








 (b) Before amending or supplementing the Preliminary Memorandum, the Time of Sale
Memorandum or the Final Memorandum, to furnish to the Representatives a copy of each such proposed amendment or supplement and not to use any such proposed amendment or supplement to which the Representatives reasonably object. 

(c) To furnish to the Representatives a copy of each proposed Additional Written Offering Communication to be prepared by or on
behalf of, used by, or referred to by the Company and not to use or refer to any proposed Additional Written Offering Communication to which the Representatives reasonably object. 

(d) If the Time of Sale Memorandum is being used to solicit offers to buy the Securities at a time when the Final Memorandum is
not yet available to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Time of Sale Memorandum in order to make the statements therein, in the light of the
circumstances, not misleading, or if, in the opinion of counsel for the Initial Purchasers, it is necessary to amend or supplement the Time of Sale Memorandum to comply with applicable law, forthwith to prepare and furnish, at its own expense, to
the Initial Purchasers and to any dealer upon request, either amendments or supplements to the Time of Sale Memorandum so that the statements in the Time of Sale Memorandum as so amended or supplemented will not, in the light of the circumstances
when delivered to a prospective purchaser, be misleading or so that the Time of Sale Memorandum, as amended or supplemented, will comply with applicable law. 

(e) If, during such period after the date hereof and prior to the date on which all of the Securities shall have been sold by
the Initial Purchasers, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Final Memorandum in order to make the statements therein, in the light of the circumstances when the Final Memorandum is
delivered to a purchaser, not misleading, or if, in the opinion of counsel for the Initial Purchasers, it is necessary to amend or supplement the Final Memorandum to comply with applicable law, forthwith to prepare and furnish, at its own expense,
to the Initial Purchasers, either amendments or supplements to the Final Memorandum so that the statements in the Final Memorandum as so amended or supplemented will not, in the light of the circumstances when the Final Memorandum is delivered to a
purchaser, be misleading or so that the Final Memorandum, as amended or supplemented, will comply with applicable law. 
 (f)
To endeavor to qualify the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions as the Representatives shall reasonably request. 

(g) To cooperate with the Representatives and use its reasonable efforts to permit the Securities to be eligible for clearance
and settlement through The Depository Trust Company. 
 (h) Whether or not the transactions contemplated in this Agreement
are consummated or this Agreement is terminated, to pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including: (i) the fees, disbursements and expenses of the Company’s counsel and
the Company’s accountants in connection with the issuance and sale of the Securities and all other fees or expenses in connection with the preparation of the Preliminary Memorandum, the Time of Sale Memorandum, the Final Memorandum, any
Additional Written Offering 

  
 14 








 
Communication prepared by or on behalf of, used by, or referred to by the Company and any amendments and supplements to any of the foregoing, including all printing costs associated therewith,
and the delivering of copies thereof to the Initial Purchasers, in the quantities herein above specified, (ii) all costs and expenses related to the transfer and delivery of the Securities to the Initial Purchasers, including any transfer or
other taxes payable thereon, (iii) the cost of printing or producing any Blue Sky or legal investment memorandum in connection with the offer and sale of the Securities under state securities laws and all expenses in connection with the
qualification of the Securities for offer and sale under state securities laws as provided in Section 6(f) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Initial Purchasers in connection with such
qualification and in connection with the Blue Sky or legal investment memorandum, up to $10,000 in the aggregate, (iv) any fees charged by rating agencies for the rating of the Securities, (v) the fees and expenses, if any, incurred in
connection with the admission of the Securities for trading any appropriate market system, (vi) the costs and charges of the Trustee and any transfer agent, registrar or depositary, (vii) the cost of the preparation, issuance and delivery
of the Securities, (viii) the costs and expenses of the Company relating to investor presentations on any “road show” undertaken in connection with the marketing of the offering of the Securities, including, without limitation,
expenses associated with the preparation or dissemination of any electronic road show, expenses associated with production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations
with the prior approval of the Company, travel and lodging expenses of the representatives and officers of the Company and any such consultants, and the cost of any aircraft chartered in connection with the road show, (ix) the document
production charges and expenses associated with printing this Agreement, (x) the fees and expenses incurred in connection with the listing of the Conversion Shares on The NASDAQ Global Select Market and (xi) all other costs and expenses
incident to the performance of the obligations of the Company hereunder for which provision is not otherwise made in this Section 6(h). It is understood, however, that except as provided in this Section 6(h), Section 8 (Indemnity and
Contribution), and the last paragraph of Section 10, the Initial Purchasers will pay all of their costs and expenses, including fees and disbursements of their counsel, transfer taxes payable on resale of any of the Securities by them and any
advertising expenses connected with any offers they may make. 
 (i) Neither the Company nor any Affiliate will sell, offer
for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in the Securities Act) which could be integrated with the sale of the Securities in a manner which would require the registration under the Securities
Act of the Securities. 
 (j) To furnish the Representatives with any proposed General Solicitation to be made by the Company
or on its behalf before its use, and not to make or use any proposed General Solicitation without the prior written consent of Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC. 

(k) While any of the Securities or the Underlying Securities remain “restricted securities” within the meaning of the
Securities Act, to make available, upon request, to any seller of such Securities the information specified in Rule 144A(d)(4) under the Securities Act, unless the Company is then subject to Section 13 or 15(d) of the Exchange Act. 

  
 15 








 (l) During the period of one year after the Closing Date or any Option Closing
Date, if later, the Company will not be, nor will it become, an open-end investment company, unit investment trust or face-amount certificate company that is or is required to be registered under Section 8 of the Investment Company Act. 

(m) Until all restrictive legends have been removed from the Securities, the Company will not, and will not permit any of its
controlled “affiliates” (as defined in Rule 144 under the Securities Act (“Rule 144”)) to resell any of the Securities or the Underlying Securities issuable upon conversion of the Securities which constitute
“restricted securities” under Rule 144 that have been reacquired by any of them (other than pursuant to a registration statement or exemption from registration under the Securities Act that results in such securities not constituting
“restricted securities” under Rule 144). 
 (n) Not to take any action prohibited by Regulation M under the
Exchange Act in connection with the distribution of the Securities contemplated hereby. 
 (o) The Company shall reserve and
keep available at all times, free of preemptive rights, the Conversion Shares for the purpose of enabling the Company to satisfy any obligations to issue the maximum number of Conversion Shares as may be issuable from time to time upon conversion of
the Securities. 
 (p) The Company shall apply the net proceeds from its sale of the Securities in the manner described under
the caption “Use of Proceeds” in the Time of Sale Memorandum and the Final Offering Memorandum. 
 (q) The Company
shall maintain, at its expense, a registrar and transfer agent for the Underlying Securities. 
 (r) Upon request of any
Initial Purchaser, to furnish, or cause to be furnished, to such Initial Purchaser, an electronic version of the Company’s trademarks, service marks and corporate logo for use on the website, if any, operated by such Initial Purchaser for the
purpose of facilitating the on-line offering of the Securities (the “License”); provided, however, that the License shall be used solely for the purpose described above, is granted without any fee and may not be
assigned or transferred. 
 The Company also agrees that, without the prior written consent of Morgan Stanley & Co. LLC on behalf
of the Initial Purchasers, it will not, during the period ending 90 days after the date of the Final Memorandum (the “Restricted Period”), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable
for common stock or (2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the common stock, whether any such transaction described in clause (1) or
(2) above is to be settled by delivery of common stock or such other securities, in cash or otherwise. The foregoing sentence shall not apply to (a) the sale of the Securities under this Agreement or any issuance of Underlying Securities
upon conversion thereof, (b) the issuance by the Company of any shares of common stock upon the exercise of an option or warrant or the conversion of a security outstanding on the date hereof of which the Initial Purchasers have been advised in
writing or for which a filing has been made under Section 16(a) of the Exchange Act, (c) the grant of options or the issuance of shares of 

  
 16 








 
common stock by the Company to employees, officers, directors, advisors or consultants of the Company pursuant to employee benefit plans in effect on the date hereof, (d) the establishment
of a trading plan pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of common stock, provided that (A) such plan does not provide for the transfer of common stock during the Restricted Period and (B) to the
extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of the Company regarding the establishment of such plan, such announcement or filing shall include a statement to the effect
that no transfer of common stock may be made under such plan during the Restricted Period, (e) the sale or issuance of or entry into an agreement to sell or issue shares of common stock or securities convertible into or exercisable for common
stock in connection with any (i) merger, (ii) acquisition of securities, businesses, property or other assets, (iii) joint ventures, (iv) strategic alliances, (v) equipment leasing arrangements or (vi) debt financing,
provided, that the aggregate number of shares of common stock, or securities convertible into or exercisable for common stock, (on an as-converted or as-exercised basis, as the case may be) that the Company may sell or issue or agree to sell
or issue pursuant to this clause (e) shall not exceed 10% of the total number of shares of the common stock issued and outstanding immediately following the completion of the transactions contemplated by this Agreement, and provided
further, that each recipient of shares of common stock or securities convertible into or exercisable for common stock pursuant to this clause (e) shall execute a lock-up agreement substantially in the form of Exhibit B hereto. For the
avoidance of doubt, the restrictions in this paragraph do not apply to the Company’s entry into and performance under or termination of the Prepaid Forward Agreements. 

7. Offering of Securities; Restrictions on Transfer. Each Initial Purchaser, severally and not jointly, represents and warrants and
agrees that: 
 (a) It is a qualified institutional buyer as defined in Rule 144A under the Securities Act (a
“QIB”) and an accredited investor within the meaning of Rule 501(a) of Regulation D under the Securities Act; 

(b) It has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or sell, the Securities by
any General Solicitation, other than a permitted communication listed on Schedule II hereto, or those made with the prior written consent of the Company, or in any manner involving a public offering within the meaning of
Section 4(a)(2) of the Securities Act; 
 (c) It has not solicited offers for, or offered or sold, and will not solicit
offers for, or offer or sell, the Securities except within the United States to persons that it reasonably believes to be QIBs in transactions pursuant to Rule 144A under the Securities Act, and that, in each case, in purchasing Securities, is
deemed to have represented and agreed as provided in the Final Memorandum under the caption “Transfer Restrictions.” 
 8.
Indemnity and Contribution.  
 (a) The Company agrees to indemnify and hold harmless each Initial Purchaser,
each person, if any, who controls any Initial Purchaser within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act, and each affiliate of any Initial Purchaser within the meaning of Rule 405 under
the Securities Act from and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action or claim) caused by
any untrue statement or alleged 

  
 17 








 
untrue statement of a material fact contained in the Preliminary Memorandum, the Time of Sale Memorandum, any Additional Written Offering Communication prepared by or on behalf of, used by, or
referred to by the Company, any General Solicitation made by the Company, any “road show” as defined in Rule 433(h) under the Securities Act (a “road show”), the Final Memorandum or any amendment or supplement thereto, or
caused by any omission or alleged omission to state therein a material fact necessary to make the statements therein in the light of the circumstances under which they were made not misleading, except insofar as such losses, claims, damages or
liabilities are caused by any such untrue statement or omission or alleged untrue statement or omission based upon information relating to any Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the
Representatives expressly for use therein. 
 (b) Each Initial Purchaser agrees, severally and not jointly, to indemnify and
hold harmless the Company, its directors, its officers and each person, if any, who controls the Company within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the foregoing
indemnity from the Company to such Initial Purchaser, but only with reference to information relating to such Initial Purchaser furnished to the Company in writing by such Initial Purchaser through the Representatives expressly for use in the
Preliminary Memorandum, the Time of Sale Memorandum, any Additional Written Offering Communication set forth in Schedule II hereto, road show, General Solicitation set forth in Schedule II hereto, the Final Memorandum or any amendment
or supplement thereto. 
 (c) In case any proceeding (including any governmental investigation) shall be instituted involving
any person in respect of which indemnity may be sought pursuant to Section 8(a) or 8(b), such person (the “indemnified party”) shall promptly notify the person against whom such indemnity may be sought (the
“indemnifying party”) in writing and the indemnifying party, upon request of the indemnified party, shall retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and any others the
indemnifying party may designate in such proceeding and shall pay the reasonably incurred fees and disbursements of such counsel related to such proceeding. In any such proceeding, any indemnified party shall have the right to retain its own
counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i) the indemnifying party and the indemnified party shall have mutually agreed to the retention of such counsel, (ii) the
indemnifying party has failed within a reasonable time to retain counsel reasonably satisfactory to the indemnified party, or (iii) the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party
and the indemnified party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood that the indemnifying party shall not, in respect of the legal
expenses of any indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all such indemnified
parties and that all such fees and expenses shall be reimbursed as they are incurred. Such firm shall be designated in writing by Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC, in the case of parties indemnified pursuant to
Section 8(a), and by the Company, in the case of parties indemnified pursuant to Section 8(b). The indemnifying party shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such
consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against any loss or liability by 

  
 18 








 
reason of such settlement or judgment. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened proceeding in
respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement (x) includes an unconditional release of such indemnified party from all
liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any indemnified party. 

(d) To the extent the indemnification provided for in Section 8(a) or 8(b) is unavailable to an indemnified party or
insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable
by such indemnified party as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Initial Purchasers on the other hand
from the offering of the Securities or (ii) if the allocation provided by clause 8(d)(i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in
clause 8(d)(i) above but also the relative fault of the Company on the one hand and of the Initial Purchasers on the other hand in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well
as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Initial Purchasers on the other hand in connection with the offering of the Securities shall be deemed to be in the same respective
proportions as the net proceeds from the offering of the Securities (before deducting expenses but after deducting discounts and commissions) received by the Company and the total discounts and commissions received by the Initial Purchasers bear to
the aggregate offering price of the Securities. The relative fault of the Company on the one hand and of the Initial Purchasers on the other hand shall be determined by reference to, among other things, whether the untrue or alleged untrue statement
of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Initial Purchasers and the parties’ relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. The Initial Purchasers’ respective obligations to contribute pursuant to this Section 8 are several in proportion to the respective principal amount of Securities they have purchased
hereunder, and not joint. 
 (e) The Company and the Initial Purchasers agree that it would not be just or equitable if
contribution pursuant to this Section 8 were determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for such purpose) or by any other method of allocation that does not take account of the
equitable considerations referred to in Section 8(d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages and liabilities referred to in Section 8(d) shall be deemed to include, subject
to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 8, no Initial
Purchaser shall be required to contribute any amount in excess of the amount by which the total price of the Securities distributed by such Initial Purchaser in the offering exceeds the amount of any damages that such Initial Purchaser has otherwise
been required to pay by reason of such untrue or alleged untrue statement or omission or 

  
 19 








 
alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation. The remedies provided for in this Section 8 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in equity. 

(f) The indemnity and contribution provisions contained in this Section 8 and the representations, warranties and other
statements of the Company contained in this Agreement shall remain operative and in full force and effect regardless of (i) any termination of this Agreement, (ii) any investigation made by or on behalf of any Initial Purchaser, any person
controlling any Initial Purchaser or any affiliate of any Initial Purchaser or by or on behalf of the Company, its officers or directors or any person controlling the Company and (iii) acceptance of and payment for any of the Securities. 

9. Termination. The Initial Purchasers may terminate this Agreement by notice given by the Representatives to the Company, if after the
execution and delivery of this Agreement and prior to the Closing Date (i) trading generally shall have been suspended or materially limited on, or by, as the case may be, any of the New York Stock Exchange, the NYSE MKT, the NASDAQ Global
Market, the Chicago Board of Options Exchange, the Chicago Mercantile Exchange or the Chicago Board of Trade or other relevant exchanges, (ii) trading of any securities of the Company shall have been suspended on any exchange or in any over-the-counter market, (iii) a material disruption in securities settlement, payment or clearance services in the United States shall have occurred, (iv) any
moratorium on commercial banking activities shall have been declared by Federal or New York State authorities or (v) there shall have occurred any outbreak or escalation of hostilities, or any change in financial markets or any calamity or
crisis that, in the Representatives’ judgment, is material and adverse and which, singly or together with any other event specified in this clause (v), makes it, in the Representatives’ judgment, impracticable or inadvisable to proceed
with the offer, sale or delivery of the Securities on the terms and in the manner contemplated in the Time of Sale Memorandum or the Final Memorandum. 

10. Effectiveness; Defaulting Initial Purchasers. This Agreement shall become effective upon the execution and delivery hereof by the
parties hereto. 
 If, on the Closing Date, or an Option Closing Date, as the case may be, any one or more of the Initial Purchasers shall
fail or refuse to purchase Securities that it has or they have agreed to purchase hereunder on such date, and the aggregate principal amount of Securities which such defaulting Initial Purchaser or Initial Purchasers agreed but failed or refused to
purchase is not more than one-tenth of the aggregate principal amount of Securities to be purchased on such date, the other Initial Purchasers shall be obligated severally in the proportions that the principal
amount of Firm Securities set forth opposite their respective names in Schedule I bears to the aggregate principal amount of Firm Securities set forth opposite the names of all such non-defaulting
Initial Purchasers, or in such other proportions as the Representatives may specify, to purchase the Securities which such defaulting Initial Purchaser or Initial Purchasers agreed but failed or refused to purchase on such date; provided that
in no event shall the principal amount of Securities that any Initial Purchaser has agreed to purchase pursuant to this Agreement be increased pursuant to this Section 10 by an amount in excess of
one-ninth of such principal amount of Securities without the written consent of such Initial Purchaser. If, on the Closing Date any Initial Purchaser or Initial Purchasers shall fail or refuse to purchase Firm
Securities which it has or they have agreed to purchase hereunder on such date and the aggregate principal amount of Securities with respect to which such default occurs is more than one-tenth of the aggregate
principal amount of Firm Securities to be purchased on such date, and arrangements satisfactory 

  
 20 








 
to the Representatives and the Company for the purchase of such Firm Securities are not made within 36 hours after such default, this Agreement shall terminate without liability on the part of
any non-defaulting Initial Purchaser or of the Company. In any such case either the Representatives or the Company shall have the right to postpone the Closing Date, but in no event for longer than seven days,
in order that the required changes, if any, in the Time of Sale Memorandum, the Final Memorandum or in any other documents or arrangements may be effected. If, on an Option Closing Date, any Initial Purchaser or Initial Purchasers shall fail or
refuse to purchase Additional Securities and the aggregate principal amount of Additional Securities with respect to which such default occurs is more than one-tenth of the aggregate principal amount of Additional Securities to be purchased on such
Option Closing Date, the non-defaulting Initial Purchasers shall have the option to (a) terminate their obligation hereunder to purchase the Additional Securities to be sold on such Option Closing Date or (b) purchase not less than the
principal amount of Additional Securities that such non-defaulting Initial Purchasers would have been obligated to purchase in the absence of such default. Any action taken under this paragraph shall not relieve any defaulting Initial Purchaser from
liability in respect of any default of such Initial Purchaser under this Agreement. 
 If this Agreement shall be terminated by the Initial
Purchasers, or any of them, because of any failure or refusal on the part of the Company to comply with the terms or to fulfill any of the conditions of this Agreement, or if for any reason the Company shall be unable to perform its obligations
under this Agreement, the Company will reimburse the Initial Purchasers or such Initial Purchasers as have so terminated this Agreement with respect to themselves, severally, for all out-of-pocket expenses (including the fees and disbursements of
their counsel) reasonably incurred by such Initial Purchasers in connection with this Agreement or the offering contemplated hereunder. 

11. Entire Agreement.  

(a) This Agreement, together with any contemporaneous written agreements and any prior written agreements (to the extent not
superseded by this Agreement) that relate to the offering of the Securities, represents the entire agreement between the Company and the Initial Purchasers with respect to the preparation of the Preliminary Memorandum, the Time of Sale Memorandum,
the Final Memorandum, the conduct of the offering, and the purchase and sale of the Securities. 
 (b) The Company
acknowledges that in connection with the offering of the Securities: (i) the Initial Purchasers have acted at arms length, are not agents of, and owe no fiduciary duties to, the Company or any other person, (ii) the Initial Purchasers owe
the Company only those duties and obligations set forth in this Agreement and prior written agreements (to the extent not superseded by this Agreement) if any, and (iii) the Initial Purchasers may have interests that differ from those of the
Company. The Company waives to the full extent permitted by applicable law any claims it may have against the Initial Purchasers arising from an alleged breach of fiduciary duty in connection with the offering of the Securities. 

12. Counterparts. This Agreement may be signed in two or more counterparts, each of which shall be an original, with the same effect as
if the signatures thereto and hereto were upon the same instrument. 

  
 21 








 13. Applicable Law. This Agreement, and any claim, controversy or dispute relating to or
arising out of this Agreement, shall be governed by and construed in accordance with the internal laws of the State of New York. 
 14.
Headings. The headings of the sections of this Agreement have been inserted for convenience of reference only and shall not be deemed a part of this Agreement. 

15. Notices. All communications hereunder shall be in writing and effective only upon receipt and if to the Initial Purchasers shall be
delivered, mailed or sent to the Representatives in care of Morgan Stanley & Co. LLC, 1585 Broadway, New York, New York 10036, Attention: Convertible Debt Syndicate Desk, with a copy to the Legal Department; and, in care of
J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, fact (212) 622-8358); Attention: Equity Syndicate Desk; and if to the Company shall be delivered, mailed or sent to FireEye, Inc., 1440 McCarthy Blvd., Milpitas,
California 95035, Attention: General Counsel, with a copy to Wilson Sonsini Goodrich & Rosati Professional Corporation, 650 Page Mill Road, Palo Alto, CA 94304, Attention: Aaron Alter and Jon Avina. 

[Signature page follows] 

  
 22 








 
			
	Very truly yours,
	
	FireEye, Inc.
		
	By:		 /s/ Michael Sheridan

	Name:		Michael Sheridan
	Title:		Senior Vice President and Chief Financial Officer


  

			
	 Accepted as of the date hereof
  

Morgan Stanley & Co. LLC
 J.P. Morgan Securities LLC

 
 Acting severally on behalf of themselves and the
several Initial Purchasers named in Schedule I hereto.

		
	By:		Morgan Stanley & Co. LLC
		
	By:		 /s/ David Oakes

	Name:		David Oakes
	Title:		Managing Director

  

			
	By:		J.P. Morgan Securities LLC
		
	By:		 /s/ Sudheer Tegulapalle

	Name:		Sudheer Tegulapalle
	Title:		Executive Director


  
 23 








 SCHEDULE I 
  

					
	 Initial Purchaser
	  	Principal Amount of Series
A Notes to be Purchased	 
	 Morgan Stanley & Co. LLC
	  	$	220,000,000	  
	 J.P. Morgan Securities LLC
	  	$	140,000,000	  
	 Nomura Securities International, Inc.
	  	$	40,000,000	  
		  	  
	  
	 
	 Total:
		$	400,000,000	  
		  	  
	  
	 

  

					
	 Initial Purchaser
	  	Principal Amount of Series
B Notes to be Purchased	 
	 Morgan Stanley & Co. LLC
	  	$	220,000,000	  
	 J.P. Morgan Securities LLC
	  	$	140,000,000	  
	 Nomura Securities International, Inc.
	  	$	40,000,000	  
		  	  
	  
	 
	 Total:
		$	400,000,000	  
		  	  
	  
	 


  
 I-1 








 SCHEDULE II 

Permitted Communications 
 Time of Sale
Memorandum 
  

	1.	Preliminary Memorandum issued May 26, 2015 

  

	2.	Pricing Term Sheet, dated May 27, 2015 

 Permitted Additional Written Offering Communications 

Each electronic “road show” as defined in Rule 433(h) furnished to the Initial Purchasers prior to use that the Initial Purchasers and Company have
agreed may be used in connection with the offering of the Securities 
 Pricing Term Sheet, dated May 27, 2015 

Permitted General Solicitations other than Permitted Additional Written Offering Communications set forth above 

None 

  
 II-1 








 EXHIBIT A 

OPINION OF COUNSEL FOR THE COMPANY 

On the basis of the foregoing and in reliance thereon and subject to the limitations and qualifications set forth herein, we are of the
opinion that: 
  

	 	1.	The Company is a corporation duly incorporated and validly existing under the laws of the State of Delaware and is in good standing under such laws. The Company has requisite corporate power to own or lease its
properties and carry on its business, as described in the Final Offering Memorandum. The Company is qualified to do business and is in good standing as a foreign corporation in the State of California. 


 

	 	2.	The execution and delivery of the Operative Documents have been duly authorized by all necessary corporate action on the part of the Company, and the Purchase Agreement has been duly executed and delivered by the
Company. 

  

	 	3.	The Company has the corporate power to execute and deliver the Operative Documents and to perform its obligations under the terms of the Operative Documents. 


 

	 	4.	The authorized capital stock of the Company is as set forth in the Final Offering Memorandum under the caption “Description of Capital Stock.” The Securities being issued on the date hereof are in the form
contemplated in the applicable Indenture and have been duly authorized by all necessary corporate action of the Company and have been duly executed by the Company and when authenticated by the Trustee in accordance with the terms of the applicable
Indenture (which authentication we have not determined by inspection of the Securities) and issued and delivered to the Initial Purchasers against payment of the purchase price therefor specified in the Purchase Agreement, the Securities will
constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms. 

  

	 	5.	Each Indenture has been duly authorized by all necessary corporate action on the part of the Company and each Indenture has been duly executed and delivered by the Company and each Indenture constitutes a valid and
binding instrument, enforceable against the Company in accordance with its terms. 

  

	 	6.	 The shares of Common Stock initially issuable upon conversion of the Securities (assuming full physical settlement of the Securities of each series
and including shares of Common Stock issuable with respect to any Make-Whole Fundamental Change (as defined in the applicable Indenture)) (the 



  
 A-1 









	 	
“Shares”) have been duly authorized and reserved by all necessary corporate action on the part of the Company and the Shares, if any, when issued upon due conversion of
the applicable Securities in accordance with the terms of such Securities and the applicable Indenture would, if issued today, be validly issued, fully paid and nonassessable and free of preemptive rights arising under the Certificate of
Incorporation or Bylaws or the DGCL. 

  

	 	7.	The statements set forth in the General Disclosure Package and the Final Offering Memorandum under the caption “Description of Notes” insofar as such statements purport to constitute a summary of the terms of
the Indentures and the Securities, fairly summarize such terms in all material respects. 

  

	 	8.	The statements set forth in the General Disclosure Package and the Final Offering Memorandum under the caption “Certain U.S. Federal Income Tax Considerations,” insofar as they purport to summarize the United
States federal tax laws referred to therein or legal conclusions with respect thereto, are fair summaries in all material respects. 

  

	 	9.	The statements set forth in the General Disclosure Package and Final Offering Memorandum under the caption “Description of Capital Stock,” insofar as such statements constitute summaries of legal matters or
documents, fairly summarize the matters and documents referred to therein in all material respects. 

  

	 	10.	The Company is not, and after giving effect to the offering and sale of the Securities and the application of the proceeds thereof as described in the General Disclosure Package, will not be required to be registered
as, an “investment company,” as such term is defined in the Investment Company Act. 

  

	 	11.	None of the issuance and sale of the Securities being delivered on the date hereof, the execution, delivery and performance by the Company of its obligations under the Purchase Agreement, the Indentures and the
Securities or the consummation of the transactions contemplated thereby will (i) violate the Certificate of Incorporation or Bylaws, (ii) conflict with, result in a breach or violation by the Company of any of the terms or provisions of,
or constitute a default by the Company under any Reviewed Agreement, (iii) result in a violation of any Reviewed Judgment, or (iv) contravene any applicable law. 


 

	 	12.	 No consent, approval, authorization, order, registration or qualification of or with any U.S. federal, New York, California or Delaware (solely with
respect to the DGCL) governmental agency or body or court is required for the execution and delivery of the Purchase Agreement, the offer, sale or issuance by the Company of the Securities or the consummation by the




  
 A-2 









	 	
Company of the transactions contemplated by the Purchase Agreement or the Indentures, except (i) such as have been obtained under the Securities Act, (ii) such as may be required under
state securities or Blue Sky laws, and (iii) as contemplated by the Operative Documents. 

  

	 	13.	Assuming the accuracy of the Initial Purchasers’ representations contained in the Purchase Agreement and the accuracy of the Company’s representations contained in the Purchase Agreement, no registration of
the Securities or the Shares is required under the Securities Act for the sale of the Securities by the Company to the Initial Purchasers pursuant to the Purchase Agreement and the Indentures or for the initial resale of the Securities by the
Initial Purchasers in the manner contemplated by the Purchase Agreement, the General Disclosure Package and the Final Offering Memorandum, and it is not necessary to qualify the Indentures under the Trust Indenture Act (it being understood that, in
each case, no opinion is expressed as to any subsequent resale of the Securities or the consequences thereof). 


  
 A-3 








 EXHIBIT B 

[FORM OF LOCK-UP LETTER] 

LOCK-UP LETTER 

            , 2015 

Morgan Stanley & Co. LLC 

      J.P. Morgan Securities LLC, as the Representatives of the several Initial Purchasers 

      listed in the Purchase Agreement referred to below 

c/o Morgan Stanley & Co. LLC 

      1585 Broadway 

      New York, NY 10036 

      J.P. Morgan Securities LLC 

      383 Madison Avenue 

      New York, NY 10179 
 Ladies
and Gentlemen: 
 The undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”) and J.P. Morgan
Securities LLC propose to enter into a Purchase Agreement (the “Purchase Agreement”) with FireEye, Inc., a Delaware corporation (the “Company”), providing for the offering (the “Offering”) by the
several initial purchasers who are parties thereto, including Morgan Stanley and J.P. Morgan Securities LLC (collectively, the “Initial Purchasers”), of Convertible Senior Notes due 2035 of the Company (the “Series A
Notes”) and Convertible Senior Notes due 2035 of the Company (the “Series B Notes,” and together with the Series A Notes, the “Securities”). Subject to the terms and conditions set forth in the Purchase
Agreement, the Securities will be convertible into shares of the Common Stock (par value $0.0001 per share) of the Company (the “Common Stock”). 

To induce the Initial Purchasers that may participate in the Offering to continue their efforts in connection with the Offering,
the undersigned hereby agrees that, without the prior written consent of Morgan Stanley on behalf of the Initial Purchasers, the undersigned will not, during the period commencing on the date hereof and ending 90 days after the date of the
final offering memorandum (the “Restricted Period”) relating to the Offering (the “Final Memorandum”), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock beneficially owned (as such term is used in Rule 13d-3 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”)), by the undersigned or any other securities so owned convertible into or exercisable or exchangeable for Common Stock or (2) enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of 

  
 B-1 








 
the Common Stock or such other securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or such other securities, in
cash or otherwise. 
 The restrictions described in the foregoing paragraph shall not apply to: 

(a) transfers of shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock (i) to the
spouse, domestic partner, parent, sibling, child or grandchild (each, an “immediate family member”) of the undersigned or to a trust formed for the benefit of the undersigned or of an immediate family member of the undersigned,
(ii) by bona fide gift, will or intestacy, (iii) if the undersigned is a corporation, partnership, limited liability company or other business entity (A) to another corporation, partnership, limited liability company or other business
entity that controls, is controlled by or is under common control with the undersigned or (B) as part of a disposition, transfer or distribution by the undersigned to its equity holders, or (iv) if the undersigned is a trust, to a trustor
or beneficiary of the trust; provided that in the case of any transfer or distribution pursuant to this clause (a), (i) each transferee, donee or distributee shall sign and deliver a lock-up agreement substantially in the form of this
agreement prior to or upon such transfer or distribution, and (ii) no filing under Section 16(a) of the Exchange Act, reporting a reduction of beneficial ownership of shares of Common Stock, shall be required or shall be voluntarily made
during the Restricted Period; 
 (b) (i) the receipt by the undersigned from the Company of shares of Common Stock upon the exercise of
options, insofar as such option is outstanding as of the date of the Final Memorandum, (ii) the transfer of shares of Common Stock or any securities convertible into Common Stock to the Company upon a vesting event of the Company’s
securities, including, without limitation, restricted stock units, or upon the exercise of options or warrants to purchase the Company’s securities on a “cashless” or “net exercise” or “net issuance” basis to cover
tax withholding obligations of the undersigned in connection with such vesting or exercise, or (iii) the sale of shares of Common Stock underlying outstanding restricted stock units to cover the payment of tax withholding obligations upon the
vesting of such awards, provided that in the case of either (i) or (ii), no filing under Section 16(a) of the Exchange Act shall be required or shall be voluntarily made within 30 days after the date of the Final Memorandum, and
after such 30th day, any filing under Section 16(a) of the Exchange Act shall clearly indicate in the footnotes thereto that (a) the filing relates to the circumstances described in (i) or (ii), as the case may be, (b) no shares
were sold by the reporting person and (c) in the case of (i), the shares received upon exercise of the option are subject to a lock-up agreement with the Initial Purchasers of the Offering; 

(c) the transfer of shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock to the Company
pursuant to agreements under which the shares were issued and the Company has the option to repurchase such shares or securities or a right of first refusal with respect to transfers of such shares or securities, provided that no filing under
Section 16(a) of the Exchange Act shall be required or shall be voluntarily made within 30 days after the date of the Final Memorandum, and after such 30th day, any filing under Section 16(a) of the Exchange Act shall clearly indicate in
the footnotes thereto that (i) the filing relates to the transfer of such shares or securities to the Company pursuant to such repurchase option or right of first refusal, as the case may be, and (ii) no shares were sold by the reporting
person; 
 (d) the establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act (“Rule 10b5-1”) for the
transfer of shares of Common Stock, provided that (i) such plan does not provide for the transfer of Common Stock during the Restricted Period and (ii) to the extent a 

  
 B-2 








 
public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of the undersigned or the Company regarding the establishment of such plan, such
announcement or filing shall include a statement to the effect that no transfer of Common Stock may be made under such plan during the Restricted Period; 

(e) the transfer of shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock that occurs solely
by operation of law or by order of a court of competent jurisdiction, provided that the transferee shall sign and deliver a lock-up agreement substantially in the form of this agreement; 

(f) the disposition by the undersigned of shares of Common Stock purchased from the Company pursuant to any employee stock purchase plan filed
with the Securities and Exchange Commission prior to the date hereof, provided that no filing under Section 16(a) of the Exchange Act shall be required or shall be voluntarily made during the Restricted Period; or 

(g) sales of Common Stock made pursuant to a trading plan pursuant to Rule 10b5-1 that has been entered into by the undersigned prior to the
date of this agreement; provided, that to the extent a public announcement or filing under the Exchange Act, if any, is required or voluntarily made by or on behalf of the undersigned or the Company regarding any such sales, such announcement
or filing shall include a statement to the effect that the sale was effected pursuant to a trading plan pursuant to Rule 10b5-1. 
 In
addition, the undersigned agrees that, without the prior written consent of Morgan Stanley on behalf of the Initial Purchasers, it will not, during the Restricted Period, make any demand for or exercise any right with respect to, the registration of
any shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock. The undersigned also agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent and registrar
against the transfer of the undersigned’s shares of Common Stock except in compliance with the foregoing restrictions. 
 This
agreement shall automatically terminate upon the earliest to occur, if any, of (a) the date the Company advises the Representatives, in writing, prior to the execution of the Purchase Agreement, that it has determined not to proceed with the
Offering, (b) the date of the termination of the Purchase Agreement if prior to the closing of the Offering, (c) August 15, 2015, if the Purchase Agreement has not been executed by that date, or (d) the consummation of a bona
fide third party tender offer, merger, consolidation or other similar transaction made to all holders of the Common Stock involving a change of control of the Company (as defined below), provided that in the event that the tender offer, merger,
consolidation or other such transaction is not completed, the Common Stock owned by the undersigned shall remain subject to the restrictions contained in this agreement. For the purposes of the immediately preceding sentence, a “change of
control” means the transfer (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons (other than the Initial Purchasers
pursuant to the Offering), of shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock if, after such transfer, the stockholders of the Company immediately prior to such transfer do not own at least
twenty percent (20%) of the outstanding voting securities of the Company (or the surviving entity). 

  
 B-3 








 The undersigned understands that the Company and the Initial Purchasers are relying upon this
agreement in proceeding toward consummation of the Offering. The undersigned further understands that this agreement is irrevocable and shall be binding upon the undersigned’s heirs, legal representatives, successors and assigns. 

Whether or not the Offering actually occurs depends on a number of factors, including market conditions. Any Offering will only be made
pursuant to a Purchase Agreement, the terms of which are subject to negotiation between the Company and the Initial Purchasers. 
  

	
	Very truly yours,
	
	  

	(Name)
	
	  

	(Address)



  
 B-4